0001012975-17-000719.txt : 20170926
0001012975-17-000719.hdr.sgml : 20170926
20170926183633
ACCESSION NUMBER: 0001012975-17-000719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170922
FILED AS OF DATE: 20170926
DATE AS OF CHANGE: 20170926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CZEREPAK ELIZABETH
CENTRAL INDEX KEY: 0001263500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32587
FILM NUMBER: 171102944
MAIL ADDRESS:
STREET 1: 201 ROUTE 17 NORTH
CITY: RUTHERFORD
STATE: NJ
ZIP: 07070
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Altimmune, Inc.
CENTRAL INDEX KEY: 0001326190
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202726770
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 2406541450
MAIL ADDRESS:
STREET 1: 19 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMATHENE, INC
DATE OF NAME CHANGE: 20071016
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP
DATE OF NAME CHANGE: 20050505
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2017-09-22
0001326190
Altimmune, Inc.
ALT
0001263500
CZEREPAK ELIZABETH
C/O ALTIMMUNE, INC.
19 FIRSTFIELD ROAD, SUITE 200
GAITHERSBURG
MD
20878
0
1
0
0
CFO and EVP Corp. Development
Stock Options (option to buy)
2.48
2017-09-22
4
A
0
62500
0
A
2017-09-22
2027-09-22
Common Stock, par value $0.0001
62500
62500
D
Stock Options (option to buy)
2.48
2017-09-22
4
A
0
62500
0
A
2019-03-31
2027-09-22
Common Stock, par value $0.0001
62500
62500
D
The option becomes exercisable, if at all, on March 31, 2019, in three equal one-third increments if the average daily closing price of Altimmune, Inc.'s common stock on Nasdaq for 10 consecutive trading days between September 22, 2017 and December 31, 2018 is at or above one of three specified thresholds, respectively.
/s/ Ori Solomon, Attorney in fact for Elizabeth Czerepak
2017-09-26